
|Articles|April 9, 2015
Oncology Drug Snapshot: Axitinib (Inlyta)
Author(s)Cancer Network Editors
This oncology drug snapshot takes a look at axitinib (Inlyta) for the treatment of advanced renal cell carcinoma (RCC) after failure of one prior systemic therapy.
Advertisement
Advertisement
Advertisement
Advertisement
























